# Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain

> **NCT02820519** · PHASE2 · TERMINATED · sponsor: **University of Witten/Herdecke** · enrollment: 4 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Loxapine

## Key facts

- **NCT ID:** NCT02820519
- **Lead sponsor:** University of Witten/Herdecke
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06-07
- **Primary completion:** 2017-05-04
- **Final completion:** 2017-05-04
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Intolerable high amount of adverse events
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02820519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02820519, "Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02820519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*